Skin and Soft Tissue
Skin and Soft Tissue
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
10
Clinical Trials
Skin and Soft Tissue
Phase II
Enrolling
nct/study# NCT06594991 / MSK-24-166
A Phase 2 study of Fianlimab, Cemiplimab, and Ipilimumab in Anti-PD-1 Refractory Melanoma
Learn More
Skin and Soft Tissue
Phase III
Enrolling
nct/study# NCT06246916 / R3767-ONC-22122
A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolumab in Participants With Unresectable or Metastatic Melanoma
Learn More
Skin and Soft Tissue
Phase III
Enrolling
nct/study# NCT06264180 / RP1-104
A Randomized, Multicenter, Phase 3 Clinical Trial of Vusolimogene Oderparepvec in Combination with Nivolumab Versus Treatment of Physician’s Choice in Patients with Advanced Melanoma That Has Progressed on an Anti-PD-1 Containing Treatment Regimen
Learn More
Skin and Soft Tissue
Phase II
Enrolling
nct/study# NCT06961006 / V940-012
A Phase 2, Randomized, Double-Blind, Placebo- and Active-Comparator Controlled Clinical Study of V940 (mRNA-4157) Plus Pembrolizumab Versus Placebo Plus Pembrolizumab in Participants With First-Line Advanced Melanoma (INTerpath-012)
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.